ArticleNeurology2026
Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.
Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Distinct characteristics and risk factors of symptomatic and incidental DWI lesions in cerebral amyloid angiopathy.Journal of neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesIncidental hyperintense lesions on diffusion-weighted imaging (DWI) are suggested as emerging marker of cerebral small vessel disease (SVD). To further determine their role in SVD, we aimed to describe their prevalence on high-resolution DWI in 2 distinct SVD types. Second, in each SVD type, we aimed to assess incidental DWI-positive lesion distribution and associations with clinical variables.
methodsData from 2 hospital-based prospective cohorts in the Netherlands and Germany were used, which included patients meeting the modified Boston criteria for probable cerebral amyloid angiopathy (CAA, BIONIC study) and patients with a confirmed diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL, VASCAMY study). In case of a stroke history, patients ≤3 months poststroke were excluded. 3T high-resolution baseline MRIs of patients with probable CAA and baseline, 18-month, and 36-month MRIs of patients with CADASIL were included. All MRI markers were rated following STRIVE-2. Within patient groups, we explored in univariable analyses the association between cardiovascular risk factors and MRI markers and incidental DWI-positive lesions and in multiple regression the association between fluid biomarkers and incidental DWI-positive lesions.
resultsBaseline data were available for 43 CAA patients (mean baseline age 71 ± 6 years, 44% female) and 75 CADASIL patients (mean baseline age 53 ± 9.9 years, 62% female). Cross-sectionally, incidental DWI-positive lesions were detected in 24/43 (56% [95% CI 41%-70%]) CAA patients and 16/75 (21% [95% CI 14%-32%]) CADASIL patients. In CAA, 65% of lesions were located in the cortex, whereas in CADASIL, 95% of lesions were located in the subcortical white or gray matter. In CAA patients, DWI-positive lesions were significantly associated with increased neurofilament light chain (NfL) in serum and CSF, but not with other CSF, MRI, or cardiovascular risk factors. In CADASIL patients, DWI-positive lesions were significantly associated with increased serum NfL, increased white matter hyperintensity volume and lacune presence. DISCUSSION: In CAA and CADASIL, the prevalence of incidental DWI-positive lesions is high, and lesions have disease-specific distribution, and associations with serum, CSF, and MRI biomarkers, suggesting that incidental DWI-positive lesions are a feature of SVD. Future studies should investigate their prognostic value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.